Information Provided By: 
Fly News Breaks for June 20, 2019
ZBH
Jun 20, 2019 | 06:39 EDT
Piper Jaffray analyst Matt O'Brien kept his Neutral rating and $120 price target on Zimmer Biomet, saying that yesterday's announcement of the resignation of its CFO Dan Florin was a "bit surprising" but does not suggest that the company's turnaround under the leadership of CEO Bryan Hanson is off track. The analyst notes that he remains "encouraged" by the company's regulatory and financial improvements, even though he still sees "significant" operating improvement as being several quarters away.
News For ZBH From the Last 2 Days
There are no results for your query ZBH
